Molecular remission induced by gemtuzumab ozogamicin associated with donor lymphocyte infusions in t(4;11) acute lymphoblastic leukemia relapsed after transplantation

被引：14

作者：

Balduzzi, A ^{[1
]}

Rossi, V ^{[1
]}

Corral, L ^{[1
]}

Bonanomi, S ^{[1
]}

Longoni, D ^{[1
]}

Rovelli, A ^{[1
]}

Conter, V ^{[1
]}

Biondi, A ^{[1
]}

Uderzo, C ^{[1
]}

机构：

[1] Univ Studi Milano Bicocca, Osped San Gerardo, Pediat Clin, I-20052 Monza, Italy

来源：

LEUKEMIA | 2003年 / 17卷 / 11期

关键词：

D O I：

10.1038/sj.leu.2403134

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2247 / 2248

页数：3

共 8 条

[1] Biological and therapeutic aspects of infant leukemia [J].

Biondi, A ;

Cimino, G ;

Pieters, R ;

Pui, CH .

BLOOD, 2000, 96 (01) :24-33

[2] Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL [J].

Cazzaniga, G ;

d'Aniello, E ;

Corral, L ;

Biondi, A .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (04) :623-638

[3] Donor leukocyte infusions in acute lymphocytic leukemia [J].

Collins, RH ;

Goldstein, S ;

Giralt, S ;

Levine, J ;

Porter, D ;

Drobyski, W ;

Barrett, J ;

Johnson, M ;

Kirk, A ;

Horowitz, M ;

Parker, P .

BONE MARROW TRANSPLANTATION, 2000, 26 (05) :511-516

[4]

GABERT J, IN PRESS LEUKEMIA

[5] Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants [J].

Keil, F ;

Prinz, F ;

Kalhs, P ;

Lechner, K ;

Moser, K ;

Schwarzinger, I ;

Jäger, U ;

Fonatsch, C ;

Worel, N ;

Mannhalter, C ;

Rabitsch, W ;

Loidolt, H ;

Schulenburg, A ;

Mitterbauer, M ;

Höcker, P ;

Greinix, HT .

LEUKEMIA, 2001, 15 (03) :355-361

[6] Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG ±Ida) and second allogeneic stem cell transplant [J].

Pawson, R ;

Potter, MN ;

Theocharous, P ;

Lawler, M ;

Garg, M ;

Yin, JAL ;

Rezvani, K ;

Craddock, C ;

Rassam, S ;

Prentice, HG .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) :622-629

[7] Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotug) therapy [J].

Rajvanshi, P ;

Shulman, HM ;

Sievers, EL ;

McDonald, GB .

BLOOD, 2002, 99 (07) :2310-2314

[8] Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia:: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin [J].

Zwaan, C ;

Reinhardt, D ;

Jürgens, H ;

Huismans, D ;

Hählen, K ;

Smith, OP ;

Biondi, A ;

van Wering, ER ;

Feingold, J ;

Kaspers, GJL .

LEUKEMIA, 2003, 17 (02) :468-470

← 1 →